UK Veterinary Oncology Market Size & Outlook, 2022-2030
UK veterinary oncology market, 2018-2030 (US$M)
Related Markets
UK veterinary oncology market highlights
- The UK veterinary oncology market generated a revenue of USD 10.5 million in 2022 and is expected to reach USD 28.0 million by 2030.
- The UK market is expected to grow at a CAGR of 13.1% from 2023 to 2030.
- In terms of segment, chemotherapy was the largest revenue generating therapy in 2022.
- Immunotherapy is the most lucrative therapy segment registering the fastest growth during the forecast period.
Veterinary oncology market data book summary
| Market revenue in 2022 | USD 10.5 million |
| Market revenue in 2030 | USD 28.0 million |
| Growth rate | 13.1% (CAGR from 2022 to 2030) |
| Largest segment | Chemotherapy |
| Fastest growing segment | Immunotherapy |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Surgery, Radiology, Chemotherapy, Immunotherapy |
| Key market players worldwide | Zoetis Inc Class A, Karyopharm Therapeutics Inc, Varian, Accuray Inc, PetCure Oncology, Boehringer Ingelheim, Elanco Animal Health Inc, One Health Group, Regeneus |
Other key industry trends
- In terms of revenue, UK accounted for 4.5% of the global veterinary oncology market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany veterinary oncology market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 2.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary Oncology Market Scope
Veterinary Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK veterinary oncology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary oncology market will help companies and investors design strategic landscapes.
Chemotherapy was the largest segment with a revenue share of 28.57% in 2022. Horizon Databook has segmented the UK veterinary oncology market based on surgery, radiology, chemotherapy, immunotherapy covering the revenue growth of each sub-segment from 2018 to 2030.
The UK has one of the largest pet populations in Europe as well as one of the highest expenditures on pets. Moreover, growing pet humanization, a high medicalization rate, improving diagnostic rate, and growing number of veterinary care centers offering oncology treatment contribute to the significant market size in the country.
For instance, Willow Veterinary Centre in the UK provides a range of medical and surgical oncology treatments for pets in the country. These include chemotherapy, surgery, metronomic (low-dose) chemotherapy, therapeutic melanoma vaccine, electrochemotherapy, and intracavitary chemotherapy.
Reasons to subscribe to UK veterinary oncology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK veterinary oncology market databook
-
Our clientele includes a mix of veterinary oncology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK veterinary oncology market, including forecasts for subscribers. This country databook contains high-level insights into UK veterinary oncology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK veterinary oncology market size, by therapy, 2016-2027 (US$M)
UK Veterinary Oncology Market Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
